The Anderson Analysis
A masterclass in the strategic forces driving industrial and systemic change.
CA
Editor
Charles Anderson
About This Column
Known for his "critical assessments" of emerging technologies, Charles Anderson brings rigorous analytical depth to a new, expansive beat. Building on a career spent at the intersection of medicine and technology, Charles now tracks the cross-industry trends where innovation meets real-world execution. He specializes in the practical application of new business models - uncovering the quantifiable benefits and the hidden challenges companies face when implementing complex transformations. His column offers actionable intelligence for leaders who value resilient, efficient, and human-centered strategies over mere hype.
Displaying items 381-400 of 866 in total
Read full article
CorMedix Soars on Blowout Quarter, Raises 2026 Financial Guidance
Read full article
AlTi Deploys AI to Supercharge Its Global UHNW Advisor Network
Read full article
The $100 Path to Property: A New Platform Tokenizes Real Estate
Read full article
Blockaid's New Shield: Real-Time Compliance for Institutional DeFi
Read full article
Thurston Group Forms Sensorium to Scale Clinical Trial Site Network
Read full article
Huhtamäki's €250M Bond Buyback: A Strategic Debt Optimization Play
Read full article
South African Innovator to Disrupt US Allergy Care with Reloadable Pen
Read full article
Optum Rx Upends PBM Model with Full Transparency Fee Structure
Read full article
GO plc Joins Connectbase to Boost Mediterranean Digital Gateway
Read full article
China & Greece: 20 Years of Partnership, from Ports to Soft Power
Read full article
Young Innovators and a City's Revival Take Center Stage in Flint
Read full article
Dutch Bros Surges in Q1, Raising Guidance Amid Market Headwinds
Read full article
PDFix-US Launches Automation Suite Amid Accessibility Compliance Crisis
Read full article
Argyle Aquaculture Plan Mired in Conflict of Interest Allegations
Read full article
AI Paradox: Contact Center Strategy Fails to Reach Frontline Agents
Read full article
Valion Bio Taps Legal-Science Hybrid to Drive Growth Strategy
Read full article
Ackman's $5B Fund Debuts to Cool Reception Amid Global Interest
Read full article
New Hope for Ovarian Cancer: $725K Funds Immune Therapy Research
Read full article
Brembo's Sensify Brakes Go Live, Redefining Automotive Safety
Read full article
UCID: 14
